The advancement of siRNA-based nanomedicine for tumor therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The advancement of siRNA-based nanomedicine for tumor therapy

Published:2024-08-15 Issue: Volume: Page:1-22
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Qiao Muchuan¹^ORCID,Zeng Chenlu¹^ORCID,Liu Changqing¹,Lei Ziwei¹,Liu Bin²,Xie Hailong¹

Affiliation:

1. Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Institute of Cancer Research, School of Medicine, University of South China, Hengyang, Hunan, 421001, China

2. College of Biology, Hunan University, Changsha, Hunan, 410082, China

Funder

Natural Science Foundation of Hunan Province

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17435889.2024.2377062

Reference148 articles.

1. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies

2. Preclinical and clinical development of siRNA-based therapeutics

3. The growth of siRNA-based therapeutics: Updated clinical studies

4. The current state and future directions of RNAi-based therapeutics

5. RNAi-based therapeutics and tumor targeted delivery in cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP